Intabio
Company

Last deal

$18M

Amount

Series B

Stage

06.02.2020

Date

3

all rounds

$35.22M

Total amount

date founded

Financing round

General

About Company
Intabio develops a real-time protein analytics platform to transform the development of biotherapeutic drugs.

Industry

Sector :

Subsector :

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The development and manufacturing of biologics require high levels of monitoring and testing, and Intabio's Blaze system addresses the acute pain in biologic product development and manufacturing by providing real-time, rapid, and direct characterization of intact protein isoforms in a simple and easy-to-use system. The Blaze system uses a proprietary microfluidic platform to separate and quantitate protein isoforms based on charge heterogeneity, and if an unknown protein peak is identified, Blaze can directly interface with a mass spectrometer to identify the specific modification.
Contacts

Contact Email

Social url

Similar Companies
1000
RedShift BioAnalytics

RedShift BioAnalytics

RedShiftBio revolutionizes protein characterization for biopharmaceutical development with advanced infrared technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Burlington, MA, USA

total rounds

7

total raised

$65.75M
Protein Dynamic Solutions

Protein Dynamic Solutions

PDS provides a biotechnology platform for real-time monitoring of proteins in solution.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Product Research

Location

Wakefield, MA 01880, USA

total rounds

4

total raised

$4.27M
IonDX

IonDX

IonDX is a bioanalytical instrumentation company that commercializes an advanced system to analyze biologic drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Monterey, CA, USA

total rounds

2

total raised

$1.12M
Andson Biotech

Andson Biotech

Andson Biotechnology develops advanced analytics for biopharmaceutical workflows.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Atlanta, GA, USA

total rounds

3

total raised

$3.6M
M&A Details
1

Transaction name

Acquired by

SCIEX

announced date

21.01.2021

Financials

Funding Rounds
7
3

Number of Funding Rounds

$35.22M

Money Raised

Their latest funding was raised on 06.02.2020. Their latest investor National Science Foundation. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Northpond Ventures

Northpond Ventures

Northpond Ventures is a science-driven venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bethesda, MD, USA

count Of Investments

111

count Of Exists

4
Northpond Ventures

Northpond Ventures

Northpond Ventures is a science-driven venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bethesda, MD, USA

count Of Investments

111

count Of Exists

4
Northpond Ventures

Northpond Ventures

Northpond Ventures is a science-driven venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bethesda, MD, USA

count Of Investments

111

count Of Exists

4
Co-Investors
Investors
5
2

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
National Science Foundation

National Science Foundation

The National Science Foundation (NSF) is an independent federal agency that funds scientific research and education in the United States.

Sector

Industrial Support Services

Subsector

Business Training and Employment Agencies

Keywords

Education

Location

Alexandria, VA, USA

count Of Investments

4486

count Of Exists

186
Genoa Ventures

Genoa Ventures

Genoa Ventures invests in early-stage life sciences technology companies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Venture Capital, Life Science

Location

San Francisco, CA, USA

count Of Investments

28

count Of Exists

2
Northpond Ventures

Northpond Ventures

Northpond Ventures is a science-driven venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bethesda, MD, USA

count Of Investments

111

count Of Exists

4

People

Founders
2
Erik Gentalen
Erik Gentalen

Erik Gentalen

Erik is the inventor of Intabio’s microfluidic-based innovations, and is responsible for advancing the technology and the overall development of the BlazeTM system. Erik has spent over 16 years developing microfluidic tools for the analysis of proteins and nucleic acids. Prior to Intabio, Erik was the Director of Systems Integration at ProteinSimple where he led the R&D team developing the Simple Western capillary immunoassay from invention to launch, and also led product support for the iCE3 capillary-based IEF system. Prior to ProteinSimple, he was the Program Manager at Caliper Life Sciences, where he led the system integration for a microfluidic research system, developed chip designs for customer applications, and managed application development collaborations with pharmaceutical partners. Erik was also an early employee at Affymetrix and Combimatrix, where his responsibilities included designing instrumentation, developing synthesis methods, managing the DNA array production facility, and collaborating on novel array applications. Erik is also a registered patent agent.

current job

Intabio
Intabio

organization founded

1

Erik Gentalen

Lena Wu
Lena Wu

Lena Wu

Lena is responsible for the company’s financing, corporate and business development strategy and execution. She was previously the CEO, President and co-founder of Rogne Biosciences, a therapeutic dermatology company. Lena has extensive management experience in companies developing and commercializing microfluidic-based products. She was the Vice-President of Corporate Development of On-Q-ity, a microfluidic-based, cancer diagnostic device company, and was also the Director of Business Development at Caliper Technologies, a microfluidic platform company developing analytical instrumentation systems for life science and diagnostic markets. Lena has 20 years of industry experience, and has advanced the strategic objectives as an operational business consultant for emerging companies across therapeutic, diagnostic and life science sectors. She began her business career at Millennium Pharmaceuticals, following a post-doc in yeast genetics at Harvard.

current job

Intabio
Intabio

organization founded

1

Lena Wu

Employee Profiles
5

Greg Bogdan

Principal engineer

Rohit Khanna

Independent director

Mary Heeney

Human resources consultant

Lena Wu

Lena Wu

CEO

Erik Gentalen

Erik Gentalen

CTO & Co-founder

Activity

Recent News
0